Literature DB >> 21366514

The origin and the clinical significance of urinary angiotensinogen in proteinuric IgA nephropathy patients.

Hye Ryoun Jang1, Soo Min Kim, Yu-Ji Lee, Jung Eun Lee, Wooseong Huh, Dae Joong Kim, Ha Young Oh, Yoon-Goo Kim.   

Abstract

BACKGROUND: Urinary angiotensinogen (AGT) was reported as a marker of renal injury in chronic kidney disease patients. However, the main source of urinary AGT is unknown in proteinuric patients because the disrupted filtration barrier might cause AGT filtration. We investigated the origin and the clinical importance of urinary AGT in proteinuric IgA nephropathy (IgAN) patients.
METHODS: In patients with biopsy-proven IgAN, urinary and plasma AGT was measured using a sandwich ELISA and compared with intrarenal AGT expression. The patients were followed up for 3 years.
RESULTS: Natural logarithm of the urinary AGT/creatinine (ln (urinary AGT/Cr)) was positively correlated with intrarenal expression of AGT (ln (urinary AGT/Cr) versus AGT/β-actin, r = 0.620, P < 0.0001; ln (urinary AGT/Cr) versus AGT density, r = 0.452, P = 0.007). Ln (urinary AGT/Cr) showed a positive correlation with urinary protein/creatinine ratio (PCR) but a negative correlation with estimated glomerular filtration rate (eGFR). Regression analyses showed that ln (urinary AGT/Cr) was a significant determinant of urinary PCR and eGFR 3 years after biopsy.
CONCLUSIONS: Urinary AGT reflects intrarenal AGT expression and correlates with the extent of proteinuria and renal function. Our study indicates the intrarenal compartment as the main source of urinary AGT, suggesting its clinical implication as an important biomarker in proteinuric IgAN patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21366514     DOI: 10.3109/07853890.2011.558518

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  11 in total

Review 1.  The role of the kidney in regulating arterial blood pressure.

Authors:  Hani M Wadei; Stephen C Textor
Journal:  Nat Rev Nephrol       Date:  2012-08-28       Impact factor: 28.314

2.  Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease.

Authors:  Maki Urushihara; Hiroyuki Kobori
Journal:  Int J Clin Med       Date:  2011-09-01

Review 3.  Urinary markers of intrarenal renin-angiotensin system activity in vivo.

Authors:  Lodi C W Roksnoer; Koen Verdonk; Anton H van den Meiracker; Ewout J Hoorn; Robert Zietse; A H Jan Danser
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

4.  Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients.

Authors:  Maki Urushihara; Takashi Nagai; Yukiko Kinoshita; Sato Nishiyama; Kenichi Suga; Natsuko Ozaki; Ariunbold Jamba; Shuji Kondo; Hiroyuki Kobori; Shoji Kagami
Journal:  Pediatr Nephrol       Date:  2014-12-20       Impact factor: 3.714

5.  Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study.

Authors:  Hyoungnae Kim; Seohyun Park; Jong Hyun Jhee; Hae-Ryong Yun; Jung Tak Park; Seung Hyeok Han; Joongyub Lee; Soo Wan Kim; Yeong Hoon Kim; Yun Kyu Oh; Shin-Wook Kang; Kyu Hun Choi; Tae-Hyun Yoo
Journal:  BMC Nephrol       Date:  2019-03-25       Impact factor: 2.388

Review 6.  Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting.

Authors:  Hui Lin; Frank Geurts; Luise Hassler; Daniel Batlle; Katrina M Mirabito Colafella; Kate M Denton; Jia L Zhuo; Xiao C Li; Nirupama Ramkumar; Masahiro Koizumi; Taiji Matsusaka; Akira Nishiyama; Martin J Hoogduijn; Ewout J Hoorn; A H Jan Danser
Journal:  Pharmacol Rev       Date:  2022-07       Impact factor: 18.923

Review 7.  Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease.

Authors:  Hiroyuki Kobori; Maki Urushihara
Journal:  Pflugers Arch       Date:  2012-08-24       Impact factor: 3.657

Review 8.  Angiotensin II blockade and renal protection.

Authors:  Hiroyuki Kobori; Hirohito Mori; Tsutomu Masaki; Akira Nishiyama
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.

Authors:  Hayne Cho Park; Ah-Young Kang; Joon Young Jang; Hyunsuk Kim; Miyeun Han; Kook-Hwan Oh; Seung Hyup Kim; Jung Woo Noh; Hae Il Cheong; Young-Hwan Hwang; Curie Ahn
Journal:  BMC Nephrol       Date:  2015-06-20       Impact factor: 2.388

10.  Urinary angiotensinogen as a surrogate marker predicting the antiproteinuric effects of angiotensin receptor blockers in patients with overt proteinuria: a multicenter prospective study.

Authors:  Junseok Jeon; Do Hee Kim; Hye Ryoun Jang; Jung Eun Lee; Wooseong Huh; Hye-Young Kim; Dae Joong Kim; Yoon-Goo Kim
Journal:  BMC Nephrol       Date:  2020-05-01       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.